Shenghua Zhan

1.3k total citations
34 papers, 954 citations indexed

About

Shenghua Zhan is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Shenghua Zhan has authored 34 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Shenghua Zhan's work include Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer-related molecular mechanisms research (3 papers). Shenghua Zhan is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer-related molecular mechanisms research (3 papers). Shenghua Zhan collaborates with scholars based in China, United States and Spain. Shenghua Zhan's co-authors include Tongguo Shi, Yanchao Ma, Ruoqin Wang, Weichang Chen, Xueguang Zhang, Guangbo Zhang, Lei Cao, Lei Cao, Xueguang Zhang and Guangbo Zhang and has published in prestigious journals such as Nature Communications, Cellular and Molecular Life Sciences and Frontiers in Immunology.

In The Last Decade

Shenghua Zhan

31 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenghua Zhan China 16 435 377 312 267 110 34 954
Rei Mizuno Japan 17 509 1.2× 454 1.2× 322 1.0× 303 1.1× 122 1.1× 46 1.2k
Anh N. Diep United States 12 422 1.0× 272 0.7× 269 0.9× 293 1.1× 161 1.5× 17 893
Jenean O’Brien United States 13 356 0.8× 590 1.6× 241 0.8× 229 0.9× 87 0.8× 15 1.1k
Lucy Ireland United Kingdom 10 353 0.8× 516 1.4× 408 1.3× 206 0.8× 138 1.3× 15 993
Gang Xiao China 20 501 1.2× 376 1.0× 197 0.6× 209 0.8× 148 1.3× 63 1.1k
David A. Leinster United Kingdom 6 383 0.9× 486 1.3× 485 1.6× 246 0.9× 68 0.6× 7 1.1k
Haimeng Yan China 12 541 1.2× 183 0.5× 314 1.0× 230 0.9× 110 1.0× 25 944
Yee Sun Tan United States 11 523 1.2× 222 0.6× 201 0.6× 432 1.6× 93 0.8× 16 981
Jinshui Fan United States 15 689 1.6× 390 1.0× 416 1.3× 250 0.9× 199 1.8× 30 1.3k
Samuel D. Saibil Canada 16 472 1.1× 389 1.0× 302 1.0× 175 0.7× 81 0.7× 48 906

Countries citing papers authored by Shenghua Zhan

Since Specialization
Citations

This map shows the geographic impact of Shenghua Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenghua Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenghua Zhan more than expected).

Fields of papers citing papers by Shenghua Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenghua Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenghua Zhan. The network helps show where Shenghua Zhan may publish in the future.

Co-authorship network of co-authors of Shenghua Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Shenghua Zhan. A scholar is included among the top collaborators of Shenghua Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenghua Zhan. Shenghua Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhan, Shenghua, Yu Shen, Lili Huang, et al.. (2025). B7-H3 and CD39 Co-Localization in Gastric Cancer: A Potential Prognostic Biomarker and Potential Dual-Target for Immunotherapy. Technology in Cancer Research & Treatment. 24. 2244122845–2244122845.
2.
Wang, Fang, Xuejiao Yu, Jun Qian, et al.. (2024). A novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancer. Drug Resistance Updates. 74. 101077–101077. 7 indexed citations
4.
Xu, Chenyang, Tianwei Guo, Shenghua Zhan, et al.. (2023). Clinical significance of CD155 expression and correlation with cellular components of tumor microenvironment in gastric adenocarcinoma. Frontiers in Immunology. 14. 1173524–1173524. 6 indexed citations
5.
Liu, Haiyan, et al.. (2023). Telocyte-Derived Exosomes Provide an Important Source of Wnts That Inhibits Fibrosis and Supports Regeneration and Repair of Endometrium. Cell Transplantation. 32. 4231270602–4231270602. 11 indexed citations
6.
Zhan, Shenghua, et al.. (2023). B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy. Journal of Cancer Research and Clinical Oncology. 149(18). 16609–16621. 8 indexed citations
7.
Zhan, Shenghua, Yu Shen, Siji Chen, et al.. (2022). Clinical significance of B7-H3 and HER2 co-expression and therapeutic value of combination treatment in gastric cancer. International Immunopharmacology. 110. 108988–108988. 7 indexed citations
8.
Chen, Yanjun, Wenying Yan, Yuqi Chen, et al.. (2022). SLC6A14 facilitates epithelial cell ferroptosis via the C/EBPβ-PAK6 axis in ulcerative colitis. Cellular and Molecular Life Sciences. 79(11). 563–563. 21 indexed citations
9.
Zheng, Zhiyuan, Yanan Li, Mengting Zhu, et al.. (2021). Lung mesenchymal stromal cells influenced by Th2 cytokines mobilize neutrophils and facilitate metastasis by producing complement C3. Nature Communications. 12(1). 6202–6202. 119 indexed citations
10.
Zhan, Shenghua, et al.. (2020). Overexpression of B7-H4 is associated with infiltrating immune cells and poor prognosis in metastatic colorectal cancer. International Immunopharmacology. 90. 107144–107144. 20 indexed citations
11.
Zhan, Shenghua, Min Zhang, Tianwei Guo, et al.. (2020). Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas. Frontiers in Oncology. 9. 1466–1466. 55 indexed citations
12.
Ma, Yanchao, Ruoqin Wang, Huimin Lu, et al.. (2020). B7-H3 promotes the cell cycle-mediated chemoresistance of colorectal cancer cells by regulating CDC25A. Journal of Cancer. 11(8). 2158–2170. 29 indexed citations
13.
Wang, Ruoqin, Yanchao Ma, Shenghua Zhan, et al.. (2020). B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression. Cell Death and Disease. 11(1). 55–55. 156 indexed citations
14.
Zhan, Shenghua, et al.. (2020). Prognostic and clinicopathologic significance of PAQR3 and VEGF-A expression in pulmonary adenocarcinoma.. PubMed. 13(7). 1676–1681. 2 indexed citations
15.
Shi, Tongguo, Yanchao Ma, Lei Cao, et al.. (2019). B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2. Cell Death and Disease. 10(4). 308–308. 184 indexed citations
16.
Jiang, Junhong, et al.. (2016). Diagnosis of a rare primary pulmonary synovial sarcoma with endobronchial ultrasound‐guided transbronchial needle aspiration. Thoracic Cancer. 7(6). 684–688. 4 indexed citations
17.
Wu, Lingzhi, et al.. (2015). [Expression and pathological mechanism of MMP-9 and HIF-2α in CD133(+) lung cancer stem cells].. PubMed. 95(32). 2607–11. 4 indexed citations
18.
Wang, Zhaoyue, Ziqiang Yu, Jian Su, et al.. (2010). A Case of Hematidrosis Successfully Treated with Propranolol. American Journal of Clinical Dermatology. 11(6). 440–443. 39 indexed citations
19.
Wang, Zhaoyue, Ziqiang Yu, Yanhua Su, et al.. (2007). Kasabach–Merritt syndrome caused by giant hemangiomas of the spleen in patients with Proteus syndrome. Blood Coagulation & Fibrinolysis. 18(5). 505–508. 5 indexed citations
20.
Zhang, Lin, et al.. (2006). [Establishment of an animal model for thyroid associated ophthalmopathy by treatment of mice with human thyrotropin receptors-activated splenocytes].. PubMed. 42(12). 1073–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026